By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmuNext Inc. 

1 Medical Center Drive

Lebanon  New Hampshire  03756  U.S.A.
Phone: Fax: n/a


SEARCH JOBS

ImmuNext develops compounds on the cutting edge of immunotherapy for cancer and autoimmune diseases. Our lead product, anti-VISTA, is partnered with Janssen for the treatment of cancer and is currently in a Phase I clinical trial. Our second product, VISTA agonists, is partnered with Hoffmann-La Roche for the treatment of autoimmune diseases. Our third product, anti-CD40L, is partnered with Sanofi for the treatment of autoimmune diseases. Other programs include a CD40 agonist for neoantigen cancer vaccines and a novel immuno-metabolic target, in each case establishing new classes of compounds.

YEAR FOUNDED:

2011

LEADERSHIP:

CEO: David DeLucia

CSO: Randolph Noelle

JOBS:

Please click here for ImmuNext job opportunities.


Key Statistics


Email: info@ImmuNext.com
Ownership: Private

Web Site: ImmuNext
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->